Zusammenfassung
Die Prognostik psychiatrischer Erkrankungen ist von vergleichbarer klinischer Bedeutung wie Diagnostik und Therapie: Nur in Kenntnis der spontanen Verlaufsprognose einer Erkrankung und deren zu erwartender Verbesserung durch ein geeignetes Therapieverfahren läßt sich die Indikation zu dessen Anwendung- und damit die Inkaufnahme etwaiger unerwünschter Begleitwirkungen - begründen. Verständlicherweise hat mit der Entwicklung hochwirksamer psychiatrischer Therapieverfahren das Interesse an der „Prädiktion“ des Behandlungserfolgs, also eines unter Nutzen/Risiko- wie Kostenaspekt begründeten Einsatzes eines Therapieverfahrens, zugenommen. Dennoch ist das gesicherte Wissen zur Prädiktion des Behandlungserfolgs in der Psychiatrie unbefriedigend. Dies liegt nicht zuletzt an unbewältigten konzeptuellen und methodischen Problemen.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Alpert M (1985) The signs and symptoms of schizophrenia. Compr Psychiatry 26: 103–112
American Psychiatric Association (APA) (1994) DSM-IV (Diagnostic and Statistical Manual of Mental Disorders), 4th edn. APA, Washington DC
Awad AG (1989) Drug therapy in schizophrenia: variability of outcome and prediction response. Can J Psychiatry 34: 711–720
Awad A (1992) Quality of life of schizophrenic patients on medications and implications for new drug trials. Hosp Commun Psychiatry 43: 262–265
Awad AG (1994) Prediction research of neuroleptic treatment outcome in schizophrenie-state of the art: 1978–1993. In: Gaebel W, Awad AG (eds) Prediction of neuroleptic treatment outcome in schizophrenia. Concepts and methods. Springer, Wien, pp 1–14
Awad AG, Hogan TP (1985) Early treatment events and prediction of response to neuroleptics in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 9: 585–588
Bartko G, Herczeg I, Bekesy M (1987) Predicting outcome of neuroleptic treatment on the basis of subjective response and early clinical improvement. J Clin Psychiatry 48: 363–365
Bielsky RJ, Friedel RO (1976) Prediction of tricyclic antidepressants response. A critical review. Arch Gen Psychiatry 33: 1479–1489
Birnbaum K (1923) Der Aufbau der Psychose. Grundzüge der psychiatrischen Strukturanalyse. Springer, Berlin
Carpenter WT, Heinrichs DW, Hanlon TE (1981) Methodologic standards for treatment outcome research in schizophrenia. Am J Psychiatry 138: 465–471
Clements K, Turpin G (1992) Vulnerability models and schizophrenia: the assessment and prediction of relapse. In: Birchwood M, Tarrier N (eds) Innovations in the psychological management of schizophrenia. Wiley, Chichester New York Brisbane Toronto Singapore, pp 21–47
Dewey SL, Smith GS, Logan J et al. (1993) Striatal binding of PET ligand 11C-Raclopride is altered by drugs that modify synaptic dopamine levels. Synapse 13: 350–356
Dilling H, Mombour W, Schmidt MH (Hrsg) (1991) Weltgesundheitsorganisation: Internationale Klassifikation psychischer Störungen. Huber, Bern Göttingen Toronto
Engel GL (1980) The clinical application of the bio-psychosocial model. Am J Psychiatry 137: 535–544
Frank E, Prien RF, Jarrett RB et al. (1991) Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. Arch Gen Psychiatry 48: 851–855
Freed WJ (1988) The therapeutic latency of neuroleptic drugs and nonspecific postjunctional supersensitivity. Schizophr Bull 14: 269–277
Freyhan FA (1957) Psychomotilität, extrapyramidale Syndrome and Wirkungsweisen neuroleptischer Therapien (Chlorpromazin, Reserpin, Prochlorperazin). Der Nervenarzt 28: 504–509
Gaebel W (1993) The importance of non-biological factors in influencing the outcome of clinic trials. Br J Psychiatry 163 [Suppl 22]: 44–50
Gaebel W, Renfordt E (eds) (1989) Objective methods for behavioral analysis in psychiatry and psychopharmacology-examples and concepts. Pharmacopsychiatry 22 [Suppl]: 1–50
Gaebel W, Awad AG (1994) Prediction research in neuroleptic therapy-future directions. In: Gaebel W, Awad AG (eds) Prediction of neuroleptic treatment outcome in schizophrenia. Concepts and methods. Springer, Wien, pp 203–209
Gaebel W, Wölwer W (1995) Affektstörungen Schizophrener. Kohlhammer, Stuttgart, in Vorbereitung
Gaebel W, Pietzcker A, Baumgartner A (1986) 3-year follow-up of schizophrenic patients-outcome dimensions and neuroleptic treatment. Pharmacopsychiatry 19: 208–209
Gaebel W, Pietzcker A, Ulrich G et al. (1988) Predictors of neuroleptic treatment response in acute schizophrenia. Pharmacopsychiatry 21: 384–386
Gaebel W, Müller-Oerlinghausen B, Schley J (1992) Early serum levels of neuroleptics do not predict therapeutic response in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 16: 891–900
Gaebel W, Frick U, Köpcke W et al. (1993) Early neuroleptic intervention in schizophrenia-are prodromal symptoms valid predictors of relapse? Br J Psychiatry 163 [Suppl 21): 8–12
Goodman A (1991) Organic unity theory: the mind-body problem revisited. Am J Psychiatry 148: 553–563
Heimchen H, Gaebel W (1987) Strategies of clinical research on neurobiological determinants of psychosis. Psychiatr Dev 5: 51–62
Hogarty GE, Goldberg SC, Collaborative Study Group (1973) Drug and sociotherapy in the aftercare of schizophrenic patients. Arch Gen Psychiatry 28: 54–64
Hsiao JK, Bartko JJ, Potter WZ (1989) Diagnosing diagnoses. Receiver operating characteristic methods and psychiatry. Arch Gen Psychiatry 46: 664–667
Hyman SE, Nestler EJ (1993) The molecular foundations of psychiatry. American Psychiatric Press, Washington London
Joyce PR, Paykel ES (1989) Predictors of drug response in depression. Arch Gen Psychiatry 46: 89–99
Kendell RE, Brockington IF, Leff JP (1979) Prognostic implications of six alternative definitions of schizophrenia. Arch Gen Psychiatry 36: 25–31
Köpcke W (1994) Design, methodological and statistical issues in prediction research of neuroleptic response. In: Gaebel W, Awad AG (eds) Prediction of neuroleptic treatment outcome in schizophrenia. Concepts and methods. Springer, Wien, pp 155–164
Kuny S, Stassen HH (1993) Speaking behaviour and voice sound characteristics in depressive patients during recovery. J Psychiatr Res 27: 289–307
Lieberman JA, Kane JM, Sarantakos S et al. (1987) Prediction of relapse in schizophrenia. Arch Gen Psychiatry 44: 597–603
May PRA, Van Putten T, Yale C et al. (1976) Predicting individual responses to drug treatment in schizophrenia: a test dose model. J Nerv Ment Dis 162: 177–183
May PRA, Goldberg SC (1978) Prediction of schizophrenic patients’ response to pharmacotherapy. In: Lipton MA, Dimascio A, Killam KF (eds) Psychopharmacology: a generation of progress. Raven Press, New York, pp 1139–1153
May PRA, Van Putten T, Yale C (1980) Predicting outcome of antipsychotic drug treatment from early response. Am J Psychiatry 137: 1088–1089
Möller HJ, Kissling W, Zerssen D von (1983) Die prognostische Bedeutung des frühen Ansprechens schizophrener Patienten auf Neuroleptika für den weiteren stationären Behandlungsverlauf. Pharmacopsychiatry 16: 46–49
Nedopil N, Rüther E (1981) Initial improvement as predictor of outcome of neuroleptic treatment. Pharmacopsychiatry 14: 205–207
Nuechterlein KH (1987) Vulnerability models for schizophrenia: state of the art. In: Häfner H, Gattaz WF, Janzarik W (eds) Search for the cause of schizophrenia. Springer, Berlin Heidelberg New York Tokyo, pp 297–316
Pickar D (1988) Perspectives on a time-dependent model of neuroleptic action. Schizophr Bull 14: 255–268
Pietzcker A, Gaebel W, Köpcke W et al. (1993) Continuous vs intermittent neuroleptic longterm treatment in schizophrenia-results of a German multicenter study. J Psychiatr Res 27: 321–339
Ranelli CJ, Miller RE (1981) Behavioral predictors of amitriptyline response in depression. Am J Psychiatry 138: 30–34
Selbach H (1961) Über die vegetative Dynamik in der psychiatrischen Pharmakotherapie. Dtsch Med J 16: 511–517
Strauss JS, Carpenter WT (1974) The prediction of outcome in schizophrenia. II. Relationships between predictor and outcome variables. Arch Gen Psychiatry 31: 37–42
Troisi A, Pasini A, Bersani G et al. (1989) Ethological predictors of amitriptyline response in depressed outpatients. J Affect Disord 17: 129–136
Van Praag HM, Kahn RS, Asnis GM et al. (1987) Denosologization of biological psychiatry or the specificity of 5-HT disturbances in psychiatric disorders. J Affect Disord 13: 1–8
Van Putten R, May PRA (1978) Subjective response as a predictor of outcome in pharmacotherapy. Arch Gen Psychiatry 35: 477–480
Woggon B (1992) Prädiktoren für das Ansprechen auf Psychopharmaka. In: Riederer P, Laux G, Pöldinger W (Hrsg) Neuro-Psychopharmaka, Bd. 1. Springer, Wien, S 475–484
Woggon B, Baumann U (1983) Multimethodological approach in psychiatric predictor research. Pharmacopsychiatry 16: 175–178
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Gaebel, W. (1996). Prädiktion des Therapieerfolges bei psychiatrischen Erkrankungen: Ein Beitrag zu Konzept und Methodik psychiatrischer Prädiktorforschung. In: Möller, HJ., Przuntek, H., Laux, G., Büttner, T. (eds) Therapie im Grenzgebiet von Psychiatrie und Neurologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-61017-2_17
Download citation
DOI: https://doi.org/10.1007/978-3-642-61017-2_17
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-60206-4
Online ISBN: 978-3-642-61017-2
eBook Packages: Springer Book Archive